Terminated |
Study Name: Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Condition: Cancer
Date: 2010-05-26
Interventions: Drug: cyproheptadine hydrochloride
|
Recruiting |
Study Name: Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Condition: Glioma Neurofibromatosis Type 1 Recurrent Childhood Pilocy
Date: 2010-03-17
Interventions: Other: Laboratory Biomarker Analysis
|
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma
Date: 2010-03-16
Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097
|
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma
Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma
Date: 2009-10-10
Interventions: Drug: vorinostat Given orally
|
Completed |
Study Name: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Condition: Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal
Date: 2009-06-27
Interventions: Drug: pazopanib hydrochloride
|
Recruiting |
Study Name: Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor
Date: 2009-06-11
Interventions: Other: cytology specimen collection procedure Correlative studies
|
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Condition: Solid Tumor Adult Central Nervous System Germ Cell Tumor A
Date: 2008-03-18
Interventions: Drug: busulfan Given IV
|
Active, not recruiting |
Study Name: Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Condition: Brain and Central Nervous System Tumors Intraocular Melanoma
Date: 2007-03-07
Interventions: Genetic: DNA analysis Other: immunologic t
|
Completed |
Study Name: AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor
Date: 2006-05-16
Interventions: Drug: Cediranib Maleate Given orally Other Names:
|
Completed |
Study Name: Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Germ Cell Tumor
Date: 2005-01-07
Interventions: Drug: irinotecan hydrochloride
|